Vanderbilt Therapeutics Clinical Research Site Archives

The “orange team,” led by Buddy Creech, MD, director of the Vanderbilt Vaccine Research Program, assembles in the old Clinical Research Center space in Medical Center North on the first day of the phase 3 Moderna vaccine study this summer.

Coronavirus ‘crusaders’ spur VUMC research achievements

Dec. 16, 2020—The development of the vaccines, monoclonal antibodies and antiviral drugs that ultimately will defeat COVID-19 wouldn’t have been possible had it not been for the unflagging and selfless efforts of a global army of research nurses, laboratory personnel, recruiters and other staff.

David Haas, MD, and Beverly Woodward, MSN, RN, are shown in a procedure room in VUMC’s Communicable Disease Response Unit. The room contains state-of-the-art infection prevention features and opens directly to the outside.

VUMC launches clinical trial of outpatient treatments for COVID-19

Sep. 2, 2020—Vanderbilt University Medical Center is now enrolling volunteers for a clinical trial of promising treatments for COVID-19 in the outpatient setting.

VUMC Reporter

Vanderbilt Therapeutics Clinical Research Site Archives

Coronavirus ‘crusaders’ spur VUMC research achievements

VUMC launches clinical trial of outpatient treatments for COVID-19

Recent Stories from VUMC News and Communications Publications